To confirm the modulation of MAGE-A6 in ANKRD1-mediated breast cancer metastasis, we performed immunoblotting of the MAGE-A6 protein in ANKRD1-overexpressing cells. This evidence concerns the gene MAGEA6 and breast carcinoma.